Mutant p53: Multiple Mechanisms Define Biologic Activity in Cancer

被引:79
作者
Kim, Michael Paul [1 ,2 ]
Zhang, Yun [2 ]
Lozano, Guillermina [2 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Genet, Houston, TX 77030 USA
来源
FRONTIERS IN ONCOLOGY | 2015年 / 5卷
关键词
mutant proteins; p53; mutation; gain of function; stroma; mouse models of cancer; TP53; cancer; GENE-EXPRESSION; STROMAL FIBROBLASTS; FUNCTION MUTATIONS; PANCREATIC-CANCER; TUMOR-SUPPRESSOR; MOUSE MODELS; HUMAN BREAST; IN-VIVO; GAIN; CELLS;
D O I
10.3389/fonc.2015.00249
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The functional importance of p53 as a tumor suppressor gene is evident through its pervasiveness in cancer biology. The p53 gene is the most commonly altered gene in human cancer; however, not all genetic alterations are biologically equivalent. The majority of alterations involve p53 missense mutations that result in the production of mutant p53 proteins. Such mutant p53 proteins lack normal p53 function and may concomitantly gain novel functions, often with deleterious effects. Here, we review characterized mechanisms of mutant p53 gain of function in various model systems. In addition, we review mutant p53 addiction as emerging evidence suggests that tumors may depend on sustained mutant p53 activity for continued growth. We also discuss the role of p53 in stromal elements and their contribution to tumor initiation and progression. Lastly, current genetic mouse models of mutant p53 in various organ systems are reviewed and their limitations discussed.
引用
收藏
页数:6
相关论文
共 50 条
  • [21] YAP enhances the pro-proliferative transcriptional activity of mutant p53 proteins
    Di Agostino, Silvia
    Sorrentino, Giovanni
    Ingallina, Eleonora
    Valenti, Fabio
    Ferraiuolo, Maria
    Bicciato, Silvio
    Piazza, Silvano
    Strano, Sabrina
    Del Sal, Giannino
    Blandino, Giovanni
    EMBO REPORTS, 2016, 17 (02) : 188 - 201
  • [22] Mutant p53 in cell-cell interactions
    Pilley, Steven
    Rodriguez, Tristan A.
    Vousden, Karen H.
    GENES & DEVELOPMENT, 2021, 35 (7-8) : 433 - 448
  • [23] Pharmacological targeting of mutant p53
    Kogan, Samuel
    Carpizo, Darren
    TRANSLATIONAL CANCER RESEARCH, 2016, 5 (06) : 698 - 706
  • [24] Gain of Function (GOF) Mutant p53 in Cancer-Current Therapeutic Approaches
    Roszkowska, Katarzyna A.
    Piecuch, Aleksandra
    Sady, Maria
    Gajewski, Zdzislaw
    Flis, Sylwia
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (21)
  • [25] Regulation of p53 activity by HIPK2: molecular mechanisms and therapeutical implications in human cancer cells
    Puca, R.
    Nardinocchi, L.
    Givol, D.
    D'Orazi, G.
    ONCOGENE, 2010, 29 (31) : 4378 - 4387
  • [26] Advanced Strategies for Therapeutic Targeting of Wild-Type and Mutant p53 in Cancer
    Zhang, Shengliang
    Carlsen, Lindsey
    Hernandez Borrero, Liz
    Seyhan, Attila A.
    Tian, Xiaobing
    El-Deiry, Wafik S.
    BIOMOLECULES, 2022, 12 (04)
  • [27] Mutant p53 promotes tumor progression and metastasis by the endoplasmic reticulum UDPase ENTPD5
    Vogiatzi, Fotini
    Brandt, Dominique T.
    Schneikert, Jean
    Fuchs, Jeannette
    Grikscheit, Katharina
    Wanzel, Michael
    Pavlakis, Evangelos
    Charles, Jol P.
    Timofeev, Oleg
    Nist, Andrea
    Mernberger, Marco
    Kantelhardt, Eva J.
    Siebolts, Udo
    Bartel, Frank
    Jacob, Ralf
    Rath, Ariane
    Moll, Roland
    Grosse, Robert
    Stiewe, Thorsten
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2016, 113 (52) : E8433 - E8442
  • [28] Mutant p53 reactivation by small molecules makes its way to the clinic
    Bykov, Vladimir J. N.
    Wiman, Klas G.
    FEBS LETTERS, 2014, 588 (16): : 2622 - 2627
  • [29] The multiple mechanisms that regulate p53 activity and cell fate
    Hafner, Antonina
    Bulyk, Martha L.
    Jambhekar, Ashwini
    Lahav, Galit
    NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2019, 20 (04) : 199 - 210
  • [30] Role of p53 in breast cancer progression: An insight into p53 targeted therapy
    Marvalim, Charlie
    Datta, Arpita
    Lee, Soo Chin
    THERANOSTICS, 2023, 13 (04): : 1421 - 1442